secwatch.observer — SEC 8-K summary
======================================

Issuer:     InspireMD, Inc. (NSPR)
CIK:        0001433607
Form:       8-K
Filed at:   2023-12-20T23:59:59+00:00
Accession:  0001493152-23-045512
Event type: other_material
Sentiment:  positive
Materiality: 0.50
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InspireMD receives U.S. patent for SwitchGuard NPS; IDE submission planned for 2024
--------------------------------------------------------------------------------

- U.S. Patent No. 11,844,893 issued for 'Shunts with Blood Flow Indicators' covering SwitchGuard NPS.
- SwitchGuard NPS designed to reverse blood flow and filter embolic debris during carotid stenting.
- Company expects to submit IDE to FDA in 2024 to initiate clinical trial for SwitchGuard NPS with CGuard Prime.
- CMS expanded coverage for carotid artery stenting to asymptomatic and standard risk patients in October 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1433607/000149315223045512/0001493152-23-045512-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1433607/000149315223045512/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-045512

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer